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This review aims to provide insight into the possible long-term neurological complications that 
COVID-19 patients may experience after the resolution of intense acute inflammation 
characterized as “cytokine storm.” Neurological symptoms such as fatigue, headache, 
dizziness, nausea, confusion, dyspnea, anorexia, malaise, myalgia, ataxia, seizure, hypogeusia, 
and hyposmia are commonly seen in these patients. COVID-19 related encephalitis is also seen 
sporadically. However, some researchers believe neuroinflammation is more common than 
what is reported. Neurological abnormalities that are linked to neuroinflammation are of 
particular concern because neuroinflammation is hypothesized to cause neurological diseases 
such as Alzheimer’s Disease, Parkinson’s Disease, and Schizophrenia. Many potential routes 
can lead to inflammation in the nervous system and elicit neuron cell death in COVID-19 
patients. These include the potential neurotropic pathway of the novel coronavirus, CNS 
parenchymal infectability, thrombotic ischemic stroke, cytokine storm, and blood-brain barrier 
breakdown. Past pandemics of similar neurotropic viruses could also offer insights regarding the 
long-term neurological effects of COVID-19. In support of our hypothesis, the Spanish Flu 
pandemic of 1918-1919 saw an increased incidence of neurodegenerative disease, Parkinson’s 
disease, and schizophrenia. We do not know exactly what the future will hold for COVID-19 
however, it is of paramount importance to attempt to anticipate and prepare for the possible 
chronic neurological sequelae and mitigate or prevent their effects. 
 
